Advertisement

ESMC

Escalon Medical Corp.

Healthcare · USD

Set alert

Price alert · ESMC

All alert types
0.18 USD 0.00 0.00%
As of Oct 30, 2026
0.17 Day range 0.17
0.14 52-week range 0.26
YTD
+5.88%
1 year
+12.50%
Open
0.17
Prev close
0.18
Mkt cap
1.33M
Vol
1.21K
Avg vol
8.07K
EPS
0.27
P/E
0.67
Div yield
0.00%
More statistics
Low
0.17
High
0.17
Forward P/E
0.00
Beta
-0.02
Short ratio
0.31
Inst. own
19.50%
Dividend
0.00
Ex-div date
50-d avg
0.241714
200-d avg
0.466145
1y target
7.00

2Y chart

Chart tools
Interval
ESMC two-year price chart0.100.190.280.370.46Oct 24Mar 25Aug 25Jan 26Jun 26Oct 26

Key statistics

Market cap
906.17K
Enterprise value
808.64K
Trailing P/E
-0.72
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.08
Price / book
0.60
EPS (TTM)
-0.166
Beta
-0.02
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-11.27%
Revenue (TTM)
11.13M
Revenue growth
-16.20%
Free cash flow
-592.11K
Total cash
372.53K
Total debt
275.00K
Return on equity
-59.40%
Shares outstanding
7.55M
Short % of float
0.03%
50-day average
0.241714
200-day average
0.466145

Analyst view

Consensus: none

Price target (mean) 7.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
ESMC Revenue — quarterly 2.60M
2019-Q2 20182019-Q3 20192019-Q4 20192020-Q1 20192020-Q2 20192020-Q3 20202020-Q4 20202021-Q1 20202021-Q2 20202021-Q3 20212021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20222022-Q4 20222023-Q1 2022
ESMC Net income — quarterly -320.72K
2019-Q2 20182019-Q3 20192019-Q4 20192020-Q1 20192020-Q2 20192020-Q3 20202020-Q4 20202021-Q1 20202021-Q2 20202021-Q3 20212021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20222022-Q4 20222023-Q1 2022
ESMC EPS — quarterly -0.05
2019-Q2 20182019-Q3 20192019-Q4 20192020-Q1 20192020-Q2 20192020-Q3 20202020-Q4 20202021-Q1 20202021-Q2 20202021-Q3 20212021-Q4 20212022-Q1 20212022-Q2 20212022-Q3 20222022-Q4 20222023-Q1 2022

Earnings

ESMC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 20240.00-0.01——
Sep 30, 2024Jun 1, 20240.000.02——
May 14, 2024Mar 1, 20240.00-0.02——
Feb 14, 2024Dec 1, 20230.00-0.01——
Nov 17, 2023Sep 1, 20230.000.00——
Oct 13, 2023Jun 1, 20230.000.01——

About Escalon Medical Corp.

Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and Europe. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. The company also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; and Ispan intraocular gases, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery, as well as a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; light source and fiber optic products that are used by vitreoretinal surgeons during surgery; and AXIS image management system for managing images through the Web from various devices regardless of modality, manufacturer, or location. The company markets its products through independent sales representatives primarily to teaching institutions, hospitals, and eye surgery centers. Escalon Medical Corp. was founded in 1987 and is based in Wayne, Pennsylvania.

Sector
Healthcare
Industry
Medical Appliances & Equipment
Country
United States

News

Your note

Sign in to keep a note on ESMC — it syncs with the Stock Master app.

Insider holders

ESMC insider holders
InsiderRelationLatest transactionDateShares held
TRUSK C TODDDirectorOwnership StatementNov 12, 2015250

Institution ownership

ESMC institution ownership
Holder% heldSharesValueReported
GRT Capital Partners, LLC7.56%571,057382.61KSep 29, 2016
BlackRock Institutional Trust Company, N.A.3.59%271,235181.73KSep 29, 2016
Renaissance Technologies, LLC2.99%225,900151.35KSep 29, 2016
Wedbush Securities Inc2.40%181,183121.39KSep 29, 2016
Vanguard Group, Inc. (The)0.79%59,31139.74KSep 29, 2016
Citadel Advisors LLC0.69%51,98434.83KSep 29, 2016

Fund ownership

ESMC fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.78%59,01146.03KJun 29, 2016
Claymore ETF Tr-Wilshire Micro Cap ETF0.13%9,8997.23KAug 30, 2016
Fidelity Extended Market Index Fund0.05%3,5122.56KAug 30, 2016
iShares Core S&P Total U.S. Stock Market ETF0.02%1,6131.18KAug 30, 2016
Quantitative Master Series Tr-Extended Market Index Series0.02%1,3991.09KJun 29, 2016
Advertisement